Filing Details
- Accession Number:
- 0001093557-19-000245
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-25 18:20:09
- Reporting Period:
- 2019-11-21
- Accepted Time:
- 2019-11-25 18:20:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534342 | Donald Abbey | 6340 Sequence Drive San Diego CA 92121 | Evp Quality And Regulatory Aff | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-11-21 | 1,318 | $218.43 | 79,232 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-21 | 3,037 | $219.65 | 76,195 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-21 | 4,259 | $220.50 | 71,936 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-21 | 2,990 | $221.16 | 68,946 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- On August 23, 2019, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- This transaction was executed in multiple trades at prices ranging from $217.98 to $218.81. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- Included in this number are 38,823 restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020.
- This transaction was executed in multiple trades at prices ranging from $219.00 to $219.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $220.00 to $220.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $221.00 to $221.86. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
